Provided by Tiger Trade Technology Pte. Ltd.

Atrium Therapeutics

8.02
+0.09001.13%
Volume:183.78K
Turnover:1.49M
Market Cap:137.19M
PE:-2.08
High:8.29
Open:8.15
Low:7.97
Close:7.93
52wk High:16.77
52wk Low:7.63
Shares:17.11M
Float Shares:15.72M
Volume Ratio:1.57
T/O Rate:1.17%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-3.8578
EPS(LYR):-3.1905
ROE:-43.98%
ROA:-399.25%
PB:0.64
PE(LYR):-2.51

Loading ...

Atrium Therapeutics initiated with an Outperform at Leerink

TIPRANKS
·
May 15

Atrium Therapeutics Inc : Leerink Partners Initiates Coverage With Outperform Rating; Target Price $25

THOMSON REUTERS
·
May 15

Corrected-Atrium Therapeutics Inc Q1 Operating Income USD -17.28 Million (Correct Source, Adds Ric)

THOMSON REUTERS
·
May 15

Corrected-Atrium Therapeutics Inc Q1 Operating Expenses USD 36.915 Million (Correct Source, Adds Ric)

THOMSON REUTERS
·
May 15

Atrium Therapeutics Q1 FY26 net loss widens to $16.63 million; revenue rises to $19.64 million

Reuters
·
May 15

Atrium Therapeutics Q1 collaboration revenue surges after spin-off

Reuters
·
May 15

Atrium Therapeutics Q1 EPS $(0.97) Beats $(1.10) Estimate, Sales $19.635M Beat $2.000M Estimate

Benzinga Earnings
·
May 15

Datar Cancer Genetics Receives Landmark US FDA Clearance for CellDx-Tissue, a Comprehensive Genomic Profiling Assay for Solid Tumors Using DNA + RNA

prnewswire
·
May 14

EVEREST MED Shares Climb Over 3% Following Release of Initial Human Data for mRNA Cancer Vaccine EVM16

Stock News
·
May 14

Wave Life Sciences to Present at 2026 RBC Capital Markets Global Healthcare Conference

GlobeNewswire
·
May 14

Thalia Therapeutics CEO Outlines Strategic Pivot to High-Value RNA Therapies

TIPRANKS
·
May 13

Capital Universities Strengthen Role as Pillars in Fundamental Research

Deep News
·
May 13

Akari Therapeutics Secures Key European Patent For Its Novel RNA Splicing Modulator ADC Payload, Strengthening Global IP Estate For All Major Global Markets

GlobeNewswire
·
May 12

ProQR Posts Q1 2026 Results as Axiomer RNA Editing Pipeline Advances

TIPRANKS
·
May 12

ProQR Announces First Quarter 2026 Operating and Financial Results

GlobeNewswire
·
May 12

ProQR Announces Multiple Upcoming Scientific Conference Presentations Highlighting the Breadth of its Axiomer™ RNA Editing Platform

GlobeNewswire
·
May 11

Korro Reports First Quarter 2026 Financial Results and Provides Corporate Update

GlobeNewswire
·
May 07

WA biotech duo takes aim at diabetes beyond Ozempic

The West Australian
·
May 07

ProQR Announces Annual General Meeting of Shareholders to be Held June 2, 2026

GlobeNewswire
·
May 04

ProQR Announces Nomination of Dr. Lykke Hinsch Gylvin to its Board of Directors

GlobeNewswire
·
Apr 30